US Stock MarketDetailed Quotes

CGON CG Oncology

Watchlist
  • 26.420
  • -0.520-1.93%
Close Mar 28 16:00 ET
  • 26.420
  • 0.0000.00%
Post 16:05 ET
1.98BMarket Cap-22.66P/E (TTM)

CG Oncology Key Stats

CG Oncology Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
--2024/Q4456.000K / 124.500K--
--2024/Q343.000K / 205.400K--
--2024/Q2111.000K / 176.330K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
--2024/Q4456.000K / 124.500K--
--2024/Q343.000K / 205.400K--
--2024/Q2111.000K / 176.330K--

Unlock Free Earnings Estimates

CG Oncology Earnings Reports

Read more

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More